vs
Side-by-side financial comparison of Organon & Co. (OGN) and Under Armour, Inc. (UAA). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.1× Under Armour, Inc.). Organon & Co. runs the higher net margin — -13.6% vs -32.4%, a 18.8% gap on every dollar of revenue. On growth, Under Armour, Inc. posted the faster year-over-year revenue change (-5.2% vs -5.3%). Under Armour, Inc. produced more free cash flow last quarter ($261.9M vs $96.0M). Over the past eight quarters, Under Armour, Inc.'s revenue compounded faster (-0.2% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Under Armour, Inc. is an American sportswear company that manufactures footwear and apparel headquartered in Baltimore, Maryland, United States.
OGN vs UAA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.3B |
| Net Profit | $-205.0M | $-430.8M |
| Gross Margin | 49.2% | 44.4% |
| Operating Margin | -9.8% | -11.3% |
| Net Margin | -13.6% | -32.4% |
| Revenue YoY | -5.3% | -5.2% |
| Net Profit YoY | -288.1% | -35013.0% |
| EPS (diluted) | $-0.78 | $-1.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $1.3B | ||
| Q3 25 | $1.6B | $1.3B | ||
| Q2 25 | $1.6B | $1.1B | ||
| Q1 25 | $1.5B | $1.2B | ||
| Q4 24 | $1.6B | $1.4B | ||
| Q3 24 | $1.6B | $1.4B | ||
| Q2 24 | $1.6B | $1.2B | ||
| Q1 24 | $1.6B | $1.3B |
| Q4 25 | $-205.0M | $-430.8M | ||
| Q3 25 | $160.0M | $-18.8M | ||
| Q2 25 | $145.0M | $-2.6M | ||
| Q1 25 | $87.0M | $-67.5M | ||
| Q4 24 | $109.0M | $1.2M | ||
| Q3 24 | $359.0M | $170.4M | ||
| Q2 24 | $195.0M | $-305.4M | ||
| Q1 24 | $201.0M | $6.6M |
| Q4 25 | 49.2% | 44.4% | ||
| Q3 25 | 53.5% | 47.3% | ||
| Q2 25 | 54.8% | 48.2% | ||
| Q1 25 | 55.6% | 46.7% | ||
| Q4 24 | 56.3% | 47.5% | ||
| Q3 24 | 58.3% | 49.8% | ||
| Q2 24 | 58.4% | 47.5% | ||
| Q1 24 | 59.0% | 45.0% |
| Q4 25 | -9.8% | -11.3% | ||
| Q3 25 | 15.2% | 1.3% | ||
| Q2 25 | 14.4% | 0.3% | ||
| Q1 25 | 6.7% | -6.1% | ||
| Q4 24 | 8.1% | 1.0% | ||
| Q3 24 | 13.1% | 12.4% | ||
| Q2 24 | 14.6% | -25.3% | ||
| Q1 24 | 14.5% | -0.3% |
| Q4 25 | -13.6% | -32.4% | ||
| Q3 25 | 10.0% | -1.4% | ||
| Q2 25 | 9.1% | -0.2% | ||
| Q1 25 | 5.8% | -5.7% | ||
| Q4 24 | 6.8% | 0.1% | ||
| Q3 24 | 22.7% | 12.2% | ||
| Q2 24 | 12.1% | -25.8% | ||
| Q1 24 | 12.4% | 0.5% |
| Q4 25 | $-0.78 | $-1.01 | ||
| Q3 25 | $0.61 | $-0.04 | ||
| Q2 25 | $0.56 | $-0.01 | ||
| Q1 25 | $0.33 | $-0.16 | ||
| Q4 24 | $0.42 | $0.00 | ||
| Q3 24 | $1.38 | $0.39 | ||
| Q2 24 | $0.75 | $-0.70 | ||
| Q1 24 | $0.78 | $0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $464.6M |
| Total DebtLower is stronger | $8.6B | $989.7M |
| Stockholders' EquityBook value | $752.0M | $1.4B |
| Total Assets | $12.9B | $4.6B |
| Debt / EquityLower = less leverage | 11.49× | 0.69× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $464.6M | ||
| Q3 25 | $672.0M | $396.0M | ||
| Q2 25 | $599.0M | $911.0M | ||
| Q1 25 | $547.0M | $501.4M | ||
| Q4 24 | $675.0M | $726.9M | ||
| Q3 24 | $763.0M | $530.7M | ||
| Q2 24 | $704.0M | $884.6M | ||
| Q1 24 | $575.0M | $858.7M |
| Q4 25 | $8.6B | $989.7M | ||
| Q3 25 | $8.8B | $1.2B | ||
| Q2 25 | $8.9B | $989.2M | ||
| Q1 25 | $9.0B | $595.1M | ||
| Q4 24 | $8.9B | $595.2M | ||
| Q3 24 | $8.7B | $594.6M | ||
| Q2 24 | $8.7B | $595.4M | ||
| Q1 24 | $8.7B | $675.8M |
| Q4 25 | $752.0M | $1.4B | ||
| Q3 25 | $906.0M | $1.9B | ||
| Q2 25 | $733.0M | $1.9B | ||
| Q1 25 | $542.0M | $1.9B | ||
| Q4 24 | $472.0M | $2.0B | ||
| Q3 24 | $493.0M | $2.0B | ||
| Q2 24 | $144.0M | $1.8B | ||
| Q1 24 | $48.0M | $2.2B |
| Q4 25 | $12.9B | $4.6B | ||
| Q3 25 | $13.6B | $4.9B | ||
| Q2 25 | $13.5B | $4.9B | ||
| Q1 25 | $13.2B | $4.3B | ||
| Q4 24 | $13.1B | $4.6B | ||
| Q3 24 | $12.8B | $4.5B | ||
| Q2 24 | $12.2B | $4.9B | ||
| Q1 24 | $11.9B | $4.8B |
| Q4 25 | 11.49× | 0.69× | ||
| Q3 25 | 9.74× | 0.64× | ||
| Q2 25 | 12.14× | 0.53× | ||
| Q1 25 | 16.52× | 0.31× | ||
| Q4 24 | 18.81× | 0.30× | ||
| Q3 24 | 17.75× | 0.30× | ||
| Q2 24 | 60.11× | 0.33× | ||
| Q1 24 | 181.54× | 0.31× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $278.1M |
| Free Cash FlowOCF − Capex | $96.0M | $261.9M |
| FCF MarginFCF / Revenue | 6.4% | 19.7% |
| Capex IntensityCapex / Revenue | 3.0% | 1.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | $-45.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $278.1M | ||
| Q3 25 | $264.0M | $-69.8M | ||
| Q2 25 | $220.0M | $48.9M | ||
| Q1 25 | $75.0M | $-202.2M | ||
| Q4 24 | $390.0M | $311.3M | ||
| Q3 24 | $141.0M | $-321.4M | ||
| Q2 24 | $332.0M | $153.0M | ||
| Q1 24 | $76.0M | $-122.9M |
| Q4 25 | $96.0M | $261.9M | ||
| Q3 25 | $218.0M | $-90.3M | ||
| Q2 25 | $181.0M | $13.5M | ||
| Q1 25 | $43.0M | $-231.0M | ||
| Q4 24 | $335.0M | $262.9M | ||
| Q3 24 | $99.0M | $-367.2M | ||
| Q2 24 | $300.0M | $107.3M | ||
| Q1 24 | $30.0M | $-156.7M |
| Q4 25 | 6.4% | 19.7% | ||
| Q3 25 | 13.6% | -6.8% | ||
| Q2 25 | 11.4% | 1.2% | ||
| Q1 25 | 2.8% | -19.6% | ||
| Q4 24 | 21.0% | 18.8% | ||
| Q3 24 | 6.3% | -26.2% | ||
| Q2 24 | 18.7% | 9.1% | ||
| Q1 24 | 1.8% | -11.8% |
| Q4 25 | 3.0% | 1.2% | ||
| Q3 25 | 2.9% | 1.5% | ||
| Q2 25 | 2.4% | 3.1% | ||
| Q1 25 | 2.1% | 2.4% | ||
| Q4 24 | 3.5% | 3.5% | ||
| Q3 24 | 2.7% | 3.3% | ||
| Q2 24 | 2.0% | 3.9% | ||
| Q1 24 | 2.8% | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | 1.65× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 3.58× | 252.26× | ||
| Q3 24 | 0.39× | -1.89× | ||
| Q2 24 | 1.70× | — | ||
| Q1 24 | 0.38× | -18.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
UAA
| Apparel | $934.0M | 70% |
| Footwear | $265.1M | 20% |
| Accessories | $107.7M | 8% |
| License | $27.2M | 2% |
